SCHEMBL4273291

SCHEMBL4273291

COc1ccc(-n2ccc3cc[c]cc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
BIRC5 O15392 1/20 0.36
ROCK1 Q13464 1/20 0.35
MAPT P10636 3/20 0.35
AURKA O14965 1/20 0.35
DAPK3 O43293 1/20 0.35
JAK2 O60674 1/20 0.35
PAK4 O96013 1/20 0.35
ABL1 P00519 1/20 0.35
NTRK1 P04629 1/20 0.35
LCK P06239 1/20 0.35
FYN P06241 1/20 0.35
CSF1R P07333 1/20 0.35
RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720122 0.88 ALDH1A1 (0.39) ALDH1A1HTTSMN1; SMN2HPGDLMNA
SCHEMBL16719505 0.79 BIRC5 (0.39) ALDH1A1HTTLMNABIRC5MAPT
SCHEMBL16720656 0.79 KCNH2 (0.45) ALDH1A1HTTSMN1; SMN2HPGDLMNA
SCHEMBL145426 0.78 BIRC5 (0.44) HTTSMN1; SMN2BIRC5PRKACA
SCHEMBL1078090 0.77 BIRC5 (0.61) ALDH1A1HTTSMN1; SMN2HPGDLMNA
SCHEMBL29896757 0.77 BIRC5 (0.61) ALDH1A1HTTSMN1; SMN2HPGDLMNA
SCHEMBL16719873 0.76 PARP1 (0.43) ALDH1A1HTTSMN1; SMN2KDM4EMAPT
SCHEMBL16720593 0.76 CYP19A1 (0.45) BIRC5MAPT
SCHEMBL16720871 0.74 POLB (0.39) ALDH1A1HTTHPGDKDM4EBIRC5
SCHEMBL10193341 0.73 ROCK1 (0.55) ALDH1A1SMN1; SMN2HPGDKDM4EROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed